| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.43 | 0.008 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.39 | 0.02 |